|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||381.5 g/mol g·mol−1|
|3D model (JSmol)|
Zolantidine is a brain-penetrating selective histamine H2 receptor (HRH2) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282. It is a benzthiazole derivative with a 30-fold higher potency for H2 receptors than other peripheral and central receptors.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|